Benralizumab reduces exacerbations in pivotal severe asthma trials

LONDON – The investigational treatment benralizumab significantly reduced the number of exacerbations that patients with severe, uncontrolled asthma experienced during the course of a year in two...
Source: Hospitalist News - Category: Hospital Management Source Type: research